MMCM
ALAB icon

Murphy & Mullick Capital Management’s Astera Labs ALAB Stock Holding History

Murphy & Mullick Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.2K Buy
394
+32
+9% +$4.56K 0.03% 303
2025
Q4 		$60.2K Buy
362
+32
+10% +$5.35K 0.04% 266
2025
Q3 		$57.7K Buy
330
+40
+14% +$6.58K 0.04% 263
2025
Q2 		$28.8K Sell
290
-35
-11% -$2.77K 0.02% 331
2025
Q1 		$19.4K Hold
325
– – 0.02% 371
2024
Q4 		$43K Buy
+325
New +$30.5K 0.04% 268

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Murphy & Mullick Capital Management's ALAB Position: Q1 2026 in Review

Murphy & Mullick Capital Management increased its Astera Labs (ALAB) stake by 8.8% in Q1 2026, buying an estimated $4.56K and bringing the position to 394 shares worth $43.2K. The position accounts for 0.03% of the portfolio, ranked #303.

Murphy & Mullick Capital Management first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $60.2K in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Murphy & Mullick Capital Management held 394 shares of Astera Labs worth $43.2K as of Q1 2026.
  • Murphy & Mullick Capital Management bought 32 Astera Labs shares in Q1 2026, an estimated $4.56K.
  • Astera Labs made up 0.03% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #303 holding.
  • Murphy & Mullick Capital Management first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • Murphy & Mullick Capital Management's Astera Labs position peaked at $60.2K in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.